Search PubMed⌕ Search

Biomedical subjects

B Vellas

Publications and source records attributed to B Vellas.

At least 109 records · Page 6Linked to original sources
PubMed1998

[Consensus statement of an interdisciplinary group of French experts on modalities of diagnosis and medical treatment of Alzheimer's disease at a treatable stage].

A group of French expert met on the 7th and 8th of February 1998 in order to establish a consensus attitude for Alzheimer's disease diagnosis and treatment. Members were drawn from primary care, geriatrics, neurology and psychiatry. They used the consensus statement of the American Association for Geriatrics, the Alzheimer's Association and the American Geriatrics Society published in JAMA, in October 1997 as a source of data for further consideration. Alzheimer's disease in the most common etiology of dementia. Main clinical features are cognitive impairment and psycho-behavioral disorders. Diagnosis must be one of inclusion and not exclusion. It is based on interviews of informants and family members and office-based clinical assessment. After a physical examination, cognitive function must be evaluated using the Mini-Mental State Examination. A laboratory evaluation should include a complete blood cell count, blood chemistry and determination of thyroid-stimulating hormone. In addition, noncontrast computed tomography head scans are adequate in most cases. Available pharmacologic treatments are not curative but are given to improve quality of life and enhance cognition and behavior. Two cholinesterases inhibitors, tacrine and donepezil, are the only agents officially authorized for treatment of the cognitive impairment in Alzheimer's disease. Mood and behaviour disorder also have to be treated by both pharmacologic and nonpharmacologic strategies. Only pharmacologic treatments will be detailed here. The consensus statements established by this group of experts will be reevaluated each year, considering the new available data on Alzheimer's disease.

Aged↗
PubMed1997

Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men.

Cross-sectional studies have demonstrated a decline in testosterone and free and bioavailable testosterone with age. This occurs in a majority of older persons without an increase in luteinizing hormone (LH), suggesting that a component of the testosterone decrease is due to secondary hypogonadism. To determine whether these findings could be duplicated in a longitudinal study, we measured testosterone, LH, follicle-stimulating hormone (FSH), and sex hormone-binding globulin (SHBG) levels in 77 men participating in the New Mexico Aging Process Study who had sera available in 1980 or 1981 and two or more serial samples in 1982, 1984, 1989, and/or 1994. Thirty-nine subjects had samples available from both 1980 and 1994. The age at entry into the study ranged from 61 to 87 years. Testosterone levels decreased over the 15 years of the study. In persons who were alive for the duration of the study, testosterone levels were significantly lower 5 years before termination of the study (P < .05). Testosterone levels did not differ at entry into the study among those who died and those who were alive at the end of the study period. Eight of 77 subjects (10%) had LH levels above the normal range at some time during the study. In contrast, 43% of subjects had elevated FSH levels. Both LH and FSH increased significantly with age. SHBG levels were measured in 1980 and 1994 and increased significantly with age (P < .0001). LH and FSH were highly correlated with one another, but neither correlated with testosterone. This study demonstrated a longitudinal decline in testosterone and an increase in LH and FSH in older men. The average rate of decrement in testosterone concentration was 110 ng/dL every decade.

Aged↗
PubMed1997

[Weight loss in patients with Alzheimer-type dementia].

Epidemiologic studies show that weight loss is commonly associated with Alzheimer's disease. It would be a manifestation of the disease itself. It is not easy to explain weight loss as subjects with Alzheimer's disease have adequete caloric intakes. Several hypothesis are considered: increased energy expenditure, biologic disturbances, dysfunction in body weight regulation, mesial cortex temporal atrophy. However, at the present time, no study can give a proper explanation. The amelioration of nutritional problems, which lead to many complications (infections, bedsores, bedridden subjects, etc), could be one of the best strategies to lessen the burden of the disease.

Aged↗
PubMed1997

Nutrition and successful aging: a study of 520 elderly persons from the Toulouse and New-Mexico Aging Process Study.

Epidemiological studies of aging are usually confronted with the presence of numerous pathologies or environmental factors which make it difficult to identify the effects of aging individually. One way of reducing the variability among individuals is to use well defined criteria to select the study population. This is the choice that was made for the New Mexico and Toulouse Aging Process Studies, which were particularly turned towards successful aging. In this study we have sought to explain the diversity of states of health of the subjects of these two studies by means of an aging classification exploring the medical history, balance and walking, and the cognitive functions. This reveals that the poorer health of certain subjects (about 10% and 30% of the populations of Toulouse and Albuquerque respectively) is slightly associated with changes in eating behaviour relative to subjects who age successfully. We have, however observed a decrease in vitamin E intake in Toulouse associated with a reduction of lipids in the food. But the poorer state of health is predominantly explained by advancing age and the occurrence of pathological states. This study confirms that aging was generally successful in the two populations studied.

Aged↗
PubMed1997

Life expectancy, comorbidity, and quality of life. A framework of reference for medical decisions.

The treatment of cancer in the elderly can benefit from increasingly sophisticated methods that measure a patient's quality of life. These measures are both general and cancer specific and herald a new and enlightened approach to patient care. The care of the older patient must be seen in light of what is known about life expectancy, the outcome of treatment, an awareness of comorbidity, and the importance of informed consent and respect for the values and preferences of the individual patient. This article reviews the growing literature on quality of life research in cancer patients.

Aged↗
PubMed1995

Techniques of assessing muscle mass and function (sarcopenia) for epidemiological studies of the elderly.

For epidemiological studies, reliable and valid measurements or indices of muscle mass are needed to screen for those elderly persons at risk for sarcopenia, and to determine the prevalence of these conditions on a national level. The methods more suitable for field or epidemiological settings are anthropometry, bioelectrical impedance, and grip strength. These field methods, while reliable, have limited demonstrated validity in their application to the elderly and are restricted by the limited functional capabilities of the elderly, which decrease with age. Epidemiological studies of the elderly need to include sufficient numbers of persons of different ethnic backgrounds, and at the older ages. For an epidemiological study of the elderly today, one also needs to select the categories of elderly persons to be included in such studies: healthy, sick, very old, handicapped, level of functional status, etc., because relationships among variables can have different statistical and biological associations. Future work should be directed at improving the design and methodology of epidemiological and serial studies so as to maximize the numbers and categories of elderly persons who can be studied.

Age Factors↗
PubMed1994

A two-centre, randomized, double-blind trial of ornithine oxoglutarate in 194 elderly, ambulatory, convalescent subjects.

In a double-blind trial, 194 ambulatory elderly patients (mean age, 74 +/- 8 years) recovering from acute illnesses were randomly assigned to receive either ornithine oxoglutarate (OGO) or a placebo. Nine subjects withdrew during the study, six in the OGO group and three in the placebo group. OGO and the placebo were administered once daily at a dose of 10 g after lunch for 2 months; the patients were monitored for a total of 4 months. Efficacy was evaluated in terms of nutritional variables, quality of life and total cost of medical treatment. The analysis involved a total of 185 patients (93 in the placebo group and 92 in the OGO group). The two groups were comparable at inclusion. After 30 and 60 days of treatment, there was a significant improvement in the following variables in the OGO group relative to the placebo group: appetite (p < 0.001), body weight (p < 0.001) and independence (p < 0.01). Two months after the end of treatment, there was still a significant improvement in the quality-of-life index (p < 0.001) and the medical-cost index (p < 0.03) in the OGO group, with an overall cost saving of 37%. We conclude that OGO seems to be a cost-effective nutritional supplement for elderly convalescent patients.

Activities of Daily Living↗
PubMed1993

Bioelectric and anthropometric assessments and reference data in the elderly.

Most studies using bioelectric impedance have estimated the volume of total body water, fat-free mass and on occasion extracellular fluid volume using whole-body resistance and reactance. However, the validity of bioelectric impedance has not been established for the elderly except in small samples of limited age ranges. The estimation of whole-body composition from impedance of body segments may be an alternative method that can be applied to many chair- and bedfast elderly patients. Also, measures of bioelectric impedance at lower and higher frequencies than 50 kHz are reported to differentiate the proportions of intra- and extracellular fluid volumes, and this could also provide important information about fluid quantities and balances in the elderly. Distribution statistics for body measurements for persons 65-85 y of age are available from the national health surveys and large clinical studies but reference data for persons > or = 80 y are sparse. Some reference data may be from groups that are not representative of the elderly because the samples were from cohorts older than elderly persons living today and significant group and racial differences existed among these as children and adults. These differences may have increased interindividual variances among the elderly. Suitable reference data for the present generations of elderly in the United States will be available with the culmination of NHANES III after 1994, but limited reference data for elderly persons up to 90 y of age have been published.(ABSTRACT TRUNCATED AT 250 WORDS)

Aged↗
PubMed1992

[Aging of digestive tract].

Recent data on ageing of the stomach, gut and pancreatic exocrine function are discussed. Ageing seems to be responsible for several physiological changes, including hyperexcitability of gastroduodenal parietal cells, alterations in the villous surface of enterocytes resulting in decreased trophicity, and decline of pancreatic exocrine secretion. However, ageing does not appear to have major consequences in healthy elderly subjects, except for poor response to such stresses as undernutrition and illness.

Aged↗
PubMed1992

[Dietary intake recommended for elderly persons].

Recommendations for dietary intake in elderly persons must account for wide interindividual variation. We propose different recommendations for: generally self sufficient elderly persons in good health. The recommended dietary intakes are very similar to those for adults, with a few exceptions (reduced calorie intake, the importance of protein and certain vitamins or minerals: vitamins B6, D, C, calcium, zinc ...); patients with an intercurrent disease or an event causing a loss of appetite and a reduction in dietary intake. Recommendations for these subjects should aim at correcting or preventing deficiencies by the use of supplementary and complementary nutritional products; subjects in a state of protein-calorie malnutrition. Recommended dietary intake should take into account the effect of malnutrition on the digestive functions of the pancreas and the intestine in the elderly. Such recommendations must be based on the findings of numerous studies now being carried out and of which we report here the first results.

Aged↗
PubMed1992

Postprandial cholecystokinin secretion in elderly with protein-energy undernutrition.

OBJECTIVE: Malnutrition is currently observed in aged people, and cholecystokinin is an important peripheral satiety signal. The aim of this study was to examine the effect of aging and protein-energy malnutrition on postprandial cholecystokinin (CCK) release. DESIGN: Non-randomized, cross-sectional comparison by age group. SETTING: Gastroenterology section of a teaching hospital. PARTICIPANTS: Twenty-one human volunteers divided into three groups: young healthy subjects (Group 1: mean 29 years, n = 7), aged healthy subjects (Group 2, mean 80 years, n = 7), and aged subjects with an important degree of malnutrition (Group 3, mean 84.6 years, n = 7). INTERVENTION: Each subject ingested a standardized liquid meal after an overnight fast. MAIN OUTCOME MEASURES: Plasma cholecystokinin was measured using a sensitive bioassay before and after the ingestion of the liquid meal. RESULTS: Basal cholecystokinin levels were similar (0.9 to 1 pM equivalent CCK-8) in the three groups. Postprandial levels were significantly increased over basal (P less than 0.05). The maximal cholecystokinin value was lower in Group 1 (3.5 +/- 0.8 pM equivalent CCK-8) and Group 2 (3.3 +/- 0.77 pM equivalent CCK-8) than in Group 3 (8.3 +/- 2 pM equivalent CCK-8) (P less than 0.05). Integrated plasma cholecystokinin was also similar in Group 1 (171 +/- 38 pM.60 min), (P less than 0.05). CONCLUSION: The increase of postprandial maximal levels of cholecystokinin is more related to malnutrition than to aging.

Adult↗
PubMed1992

[Fracture of the upper extremity of the femur in elderly women: respective role of fall and bone demineralization].

Fractures of the proximal femur in elderly individuals are becoming increasingly common in the industrialized world and represent a heavy burden in both socioeconomic and human terms. Two factors are key to the pathophysiology of these fractures: falls and decreased bone strength due to osteoporosis. Femoral and vertebral bone density was measured in 40 elderly women (83 +/- 5 years) who experienced a fall; in those who developed a femoral fracture as a result of the fall, femoral bone density was lower by 12 to 21% (z score: -0.7 to -1.04) than in those with no fracture, after adjustment for age, height and weight. Femoral neck and trochanteric area measurements had the best predictive value (area under the RoC curve: 75% +/- 8%). These was no difference by anatomic fracture type (neck or trochanter). Patients with pertrochanteric fractures had lower vertebral bone densities than controls. These findings, together with recent prospective data, demonstrate that in addition to falls, bone loss (osteoporosis) promotes the occurrence of fractures of the proximal femur in elderly patients. This has important practical implications for the detection and prevention of these fractures.

Accidental Falls↗